JOHNSON & JOHNSON SERVICES INC

Organization · NJ
Hires government relations

Who they hire

JOHNSON & JOHNSON SERVICES, INC.
2024 · 2 filings · Bankruptcy, Budget/Appropriations, Consumer Issues/Safety/Products, Copyright/Patent/Trademark, Environment/Superfund, Health Issues, Labor Issues/Antitrust/Workplace, Law Enforcement/Crime/Criminal Justice, Medicare/Medicaid, Pharmacy, Science/Technology, Taxation/Internal Revenue Code, Trade (domestic/foreign), Veterans
$██,███ / qtrUnlock

What they lobby on

- HR 4490, "To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the to the ultimate user, and for other purposes", regarding all provisions. - Issues related to drug shortages.
Pharmacy · 2024 Q2
- HR 5488 and S 2805, the "Protecting our Courts from Foreign Manipulation Act", regarding all provisions - Issues related to transparency in third-party litigation funding
Law Enforcement/Crime/Criminal Justice · 2024 Q2
- Issues related to Veterans Administration and Veterans Health Administration policy, procurement, and contracting processes for medical technology.
Veterans · 2024 Q2
- Issues related to diversity, equity and inclusion.
Labor Issues/Antitrust/Workplace · 2024 Q2
- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. - HR 7174, "Ensuring Pathways to Innovative Cures (EPIC) Act", regarding all provisions - HR 8574, the "340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act", regarding all provisions - HR 7384, "Creating Hope Reauthorization Act", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program - the SUSTAIN 340B Act
Health Issues · 2024 Q2